Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · IEX Real-Time Price · USD
9.80
-0.01 (-0.10%)
At close: Jul 19, 2024, 4:00 PM
10.03
+0.23 (2.35%)
Pre-market: Jul 22, 2024, 7:05 AM EDT
Travere Therapeutics Market Cap
Travere Therapeutics has a market cap or net worth of $746.06 million as of July 22, 2024. Its market cap has decreased by -33.91% in one year.
Market Cap
746.06M
Enterprise Value
709.04M
1-Year Change
-33.91%
Ranking
Category
Stock Price
$9.80
Market Cap Chart
Since December 31, 2012, Travere Therapeutics's market cap has increased from $40.40M to $746.06M, an increase of 1,746.69%. That is a compound annual growth rate of 28.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 746.10M | 10.44% |
| Dec 29, 2023 | 675.60M | -49.94% |
| Dec 30, 2022 | 1.35B | -28.99% |
| Dec 31, 2021 | 1.90B | 36.59% |
| Dec 31, 2020 | 1.39B | 128.10% |
| Dec 31, 2019 | 610.00M | -34.65% |
| Dec 31, 2018 | 933.40M | 12.70% |
| Dec 29, 2017 | 828.20M | 15.95% |
| Dec 30, 2016 | 714.30M | 2.44% |
| Dec 31, 2015 | 697.30M | 113.37% |
| Dec 31, 2014 | 326.80M | 153.92% |
| Dec 31, 2013 | 128.70M | 218.56% |
| Dec 31, 2012 | 40.40M | - |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OrthoPediatrics | 776.11M |
| Erasca | 766.54M |
| Embecta | 759.52M |
| Phibro Animal Health | 754.99M |
| Evolus | 748.82M |
| Pliant Therapeutics | 745.63M |
| 4D Molecular Therapeutics | 744.53M |
| Nuvation Bio | 743.01M |